A meta-analysis of 21 studies, analyzing the association between obesity, hormone receptor, and menopausal status [20], reported increased pooled HR for OS in heavier vs. lighter women both in ER+/PR+ and ER−/PR− cancers and in pre- and postmenopausal women groups. This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.